| Pharmaceutical active ingredients: |
| Betamethasone ValerateNeomycin Sulfate |
| Available forms, composition and doses of Betnovat med Neomycin: |
| N / A |
| Betnovat med Neomycin medical category: |
| Human:Topical anti-infectives with corticosteroids |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D07CC01 - Betamethasone and antibiotics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKline |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Betnelan Neomycine | Betamethasone Valerate; Neomycin Sulfate | GlaxoSmithKline |
| Betnelan-VN | Betamethasone Valerate; Neomycin Sulfate | GlaxoSmithKline |
| Betnesol-VN | Betamethasone Valerate; Neomycin Sulfate | GlaxoSmithKline |
| Betneval Neomycine | Betamethasone Valerate; Neomycin Sulfate | GlaxoSmithKline |
| Betnosone N | Betamethasone Valerate; Neomycin Sulfate | Hoe Pharmaceuticals |
| Betnovate-N | Betamethasone Valerate; Neomycin Sulfate | GlaxoSmithKline; Firma Chun Cheong; Zuellig Pharma |
| Bevalex | Betamethasone Valerate; Neomycin Sulfate | Molex Ayus Pharmaceutical |
| Celestoderm met Neomycine | Betamethasone Valerate; Neomycin Sulfate | Schering-Plough |
| Celestoderm Neomycine | Betamethasone Valerate; Neomycin Sulfate | Schering-Plough |
| Celestoderm-V with Neomycin | Betamethasone Valerate; Neomycin Sulfate | Schering-Plough |